Optos plc, a retinal imaging company, develops, manufactures, and markets ultra-widefield imaging devices to eye-care professionals in the United Kingdom and internationally. The company’s medical devices produce high-resolution optomap images by facilitating early detection, management, and treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. It offers Silverstone, an UWF retinal imaging device that captures optomap guided OCT scanning across the retina and into the far periphery; Monaco, a UWF imaging device with integrated OCT to enhance clinical exam; and Daytona, an UWF retinal imaging device. The company’s retinal imaging devices include California rg devices, which are designed to facilitate retinal exams and document findings; California fa devices for diagnosis and management of diabetic eye diseases and other vascular diseases; and California icg developed for retinal specialist for management of AMD, uveitic condition, and other choroidal pathology. In addition, it provides OptosAdvance, an image management solution for eye care to manage clinical eye care data; OptosCloud, a storage solution for eye care; and V2 Vantage Pro, a software used to view the images from Optos UWF imaging devices. The company was incorporated in 1992 and is based in Dunfermline, United Kingdom. Optos plc operates as a subsidiary of Nikon Corporation.